A genus of Gram-positive facultative anaerobes that occupy niches ranging from benign commensals (dental plaque, skin) to acute pathogens (pharyngitis, impetigo, invasive disease). Streptococci are uniquely manganese-dependent for catalytic scavenging of reactive oxygen species, a trait that distinguishes them from many other pathogenic bacteria and provides both metabolic advantage and therapeutic vulnerability.
Taxonomy and Major Groups
- *Group A Streptococcus (GAS / S. pyogenes) -- causes pharyngitis, scarlet fever, rheumatic fever, and acute postinfectious glomerulonephritis (APIGN). Leads to ~111,500 deaths annually worldwide; post-infectious sequelae are the primary long-term public health burden.
- Group B Streptococcus (GBS / S. agalactiae) -- vaginal colonizer; causes neonatal meningitis and sepsis (leading cause of bacterial meningitis in infants <3 months), chorioamnionitis, and preterm birth complications.
- Streptococcus pneumoniae -- causes community-acquired pneumonia, otitis media, meningitis. Encapsulated, invasive in immunocompromised hosts.
- Streptococcus mutans -- dental caries pathogen. Acidogenic biofilm former; produces lactic acid from sucrose fermentation, driving enamel demineralization.
- Streptococcus thermophilus* -- GRAS (Generally Recognized as Safe) organism; probiotic strain used in yogurt and dairy fermentation.
Manganese Dependency -- A Unique Metabolic Strategy
Manganese-Dependent Superoxide Dismutase (MnSOD)
- Streptococci rely on MnSOD (not the more common FeSOD) as their primary defense against oxidative stress.
- MnSOD catalyzes the dismutation of superoxide radical (O2·−) to hydrogen peroxide and molecular oxygen, protecting intracellular proteins from oxidative damage.
- This manganese preference represents an evolutionary adaptation to environments where iron is sequestered by host nutritional immunity mechanisms like lactoferrin and transferrin.
Virulence and Manganese Availability
- Manganese availability modulates streptococcal virulence: MnSOD-deficient mutants show reduced survival in macrophages and attenuated pathogenicity in murine models.
- In the throat and tonsil environment during acute infection, local manganese availability (vs. iron sequestration) may favor GAS expansion and persistence.
- Calprotectin at inflammation sites sequesters both zinc and iron but not manganese, potentially creating a selective pressure for Mn-dependent pathogens during immune response.
Major Virulence Factors
Group A Streptococcus (GAS) Virulence Arsenal
- M protein -- antiphagocytic, cross-reactive with myosin (molecular mimicry; triggering post-streptococcal sequelae).
- Hyaluronidase -- cleaves hyaluronic acid in connective tissue; enhances invasiveness and tissue spread.
- Streptokinase -- plasminogen activator; converts plasminogen to plasmin for fibrin degradation and dissemination.
- Streptolysins O and S -- pore-forming toxins that lyse red blood cells and immune cells; drive inflammation and necrotic tissue damage.
- Streptopain (cysteine protease) -- cleaves complement and immunoglobulin, subverting adaptive immunity.
Group B Streptococcus (GBS) Virulence
- Capsule (polysialic acid) -- mimics host neural tissue, evading immune recognition; prevents phagocytosis.
- Beta-hemolysin/cytolysin -- pore-forming toxin; damages epithelial and immune cells.
- Serine protease SpeCE -- cleaves IgA, fibrinogen, and complement factors.
Streptococcus mutans
- Glucosyltransferases (GTFs) -- synthesize insoluble dextran polysaccharide from dietary sucrose; primary biofilm matrix.
- Acidogenic metabolism -- lactate fermentation drives pH <5, creating aciduric niche.
- Acid tolerance -- ATP-dependent H+ pumping allows survival at pH 4.0 in biofilm microenvironments.
Disease Associations
Acute Infection
- Pharyngitis: GAS causes 10-20% of bacterial pharyngitis cases; diagnosis guides antibiotic intervention to prevent rheumatic sequelae.
- Necrotizing fasciitis: Rapidly progressive streptococcal cellulitis with high mortality; requires surgical debridement.
- Neonatal sepsis: GBS acquisition from maternal vaginal microbiota during delivery; 1-2 per 1,000 live births; preventable via intrapartum antibiotic prophylaxis.
Post-Infectious Sequelae
- Acute Rheumatic Fever (ARF) -- develops 2-4 weeks after untreated GAS pharyngitis; affects 1-3% of infected children in developed countries, 5-10% in low-income settings. Cardiac involvement (rheumatic heart disease) is a leading cause of preventable mortality in children globally.
- Molecular mimicry between GAS M protein and cardiac myosin, tropomyosin, and keratin triggers autoimmune heart inflammation.
- Autoantibodies cross-react with cardiac valve proteins, driving valve fibrosis and stenosis.
- Post-Infectious Glomerulonephritis (PIGN) -- immune complex deposition in kidney glomeruli; develops in 1-5% of GAS-infected individuals; can progress to ESRD if untreated.
- PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infection) -- controversial post-infectious OCD/tics; molecular mechanism remains unproven; antibody-mediated striatal dysfunction proposed but not yet established.
Chronic Biofilm States
- Dental caries -- S. mutans initiates plaque biofilm; cavity incidence correlates with dietary sucrose and bacterial load.
- Chronic tonsillitis -- persistent GAS carriage in tonsillar crypts; recurrent infections and occasional abscesses.
Role in the Microbiome
- Oral biofilm: Streptococci are primary pioneers of dental plaque; establish pH microenvironments that enable secondary colonizers (Actinomyces, Veillonella).
- Throat microbiota: Transient in healthy individuals; persists during acute infection; clearance typically occurs with antibiotic or immune control.
- Gut: Not a primary resident; occasional detection reflects oropharyngeal aspiration rather than stable colonization.
Ecological Context
- Streptococci thrive in anaerobic biofilms (dental, tonsillar) where manganese availability exceeds iron.
- M protein and capsular polymers enable coexistence with host tissues through anti-phagocytic camouflage.
- Biofilm matrix (hyaluronate-cross-linked, carbohydrate-rich) sequesters antimicrobial peptides and antibodies, enabling persistence despite active immune response.
Manganese Sequestration as Therapeutic Strategy
- Calprotectin elevation (during inflammation or in IBD/infection) sequesters zinc and iron but may allow manganese to remain available.
- Experimental approaches: Manganese chelators or dietary manganese restriction may synergize with antibiotics against streptococcal infections by blocking MnSOD-dependent stress survival.
- Probiotics with alternative superoxide defenses (e.g., FeSOD-dependent organisms) may competitively exclude streptococci in biofilms.
Connections
- manganese -- essential cofactor for MnSOD; Mn availability modulates virulence
- zinc -- competing metal in calprotectin; possible bioavailability interactions
- iron -- sequestered by host as defense; streptococci bypass via Mn-dependent metabolism
- superoxide dismutase -- MnSOD is critical virulence-enabling enzyme
- nutritional immunity -- host metal sequestration selects for Mn-dependent pathogens
- biofilm -- carbohydrate matrix protects against antimicrobials and immune attack
- molecular mimicry -- M protein cross-reactivity with cardiac myosin (ARF pathogenesis)
- rheumatic heart disease -- post-streptococcal sequela with global disease burden
- oral microbiome -- plaque pioneer; acidogenic niche developer